SSSSL Q1 2026 Earnings Massive EPS Beat Driven by Investment Gains Notes Unchanged Marker Therapeutics Inc MRKR Q1 2026 Earnings EPS Beat Expectations Amid Development Stage Operations AGNCZ Q1 2026 Earnings Preferred EPS Surpasses Estimates by 145 Jade Biosciences Inc JBIO Q1 2026 Earnings EPS Miss Amid Continued PreRevenue Phase Neurocrine Biosciences NBIX Q1 2026 Earnings EPS Smashes Estimates Stock Edges Higher